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Abstract
Techniques using machine learning for short term blood glucose level prediction in patients
with Type 1 Diabetes are investigated. This problem is significant for the development of
effective artificial pancreas technology so accurate alerts (e.g. hypoglycemia alarms) and
other forecasts can be generated. It is shown that two factors must be considered when
selecting the best machine learning technique for blood glucose level regression: (i) the
regression model performance metrics being used to select the model, and (ii) the prepro-
cessing techniques required to account for the imbalanced time spent by patients in different
portions of the glycemic range. Using standard benchmark data, it is demonstrated that dif-
ferent regression model/preprocessing technique combinations exhibit different accuracies
depending on the glycemic subrange under consideration. Therefore technique selection
depends on the type of alert required. Specific findings are that a linear Support Vector
Regression-based model, trained with normal as well as polynomial features, is best for
blood glucose level forecasting in the normal and hyperglycemic ranges while a Multilayer
Perceptron trained on oversampled data is ideal for predictions in the hypoglycemic range.
Introduction
Type 1 Diabetes (T1D) is an autoimmune disease where the pancreas produces little to no
insulin [1]. Conventional therapy requires patients to inject themselves with insulin multiple
times per day. However, with more recent advancements in technology, specifically systems
known as artificial pancreases (APs), improved glycemic control is now possible [2].
The standard AP consists of three main components. Firstly, there is a continuous glucose
monitor (CGM) which monitors glycemic levels via a small sensor inserted subcutaneously in
either the forearm or the abdomen. The second component is an insulin delivery system, typi-
cally a continuous pump, which delivers insulin at either a user-specified or an automatically
determined basal rate, also subcutaneously. Thirdly, there is a micro-controller linking the two
devices together wirelessly, whose main purpose is regulating the insulin pump rate such that
time spent in normoglycemia is maximised. Additionally, a dedicated reader or a smartphone
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may also be used so the patient can observe their current and recent past glucose levels, along
with the status of the pump, in real time or on-demand.
Despite these technological improvements, most patients with T1D are still not able to
achieve near-normal glycemia, and remain at risk of severe hypoglycemia and diabetic ketoaci-
dosis [3, 4], albeit with a lower probability than patients undergoing non-AP treatment. This
risk is primarily due to the insulin pumps themselves not responding adequately to changing
glycemia, one dimension of which is the inability of the controller to accurately forecast short
term future glycemic levels.
Consequently, several studies have reported on the benefits of being able to predict hypo-
glycemia in patients with T1D as a way to improve clinical outcomes [5–7], and alerts can eas-
ily be built into existing monitoring software if the patient is using a CGM only or a full AP [8,
9]. In this paper, the focus is on the application of machine learning for predicting glycemic
levels which can then be used for generating alerts. Examples of the current level of interest in
applying artificial intelligence and machine learning techniques to this problem are illustrated
by two recent extensive survey papers on the topic [10, 11].
The main contributions of this paper are as follows. Firstly, the predictive performance met-
rics used for assessing different machine learning techniques and selecting the best single tech-
nique are considered. It is shown, via an extensive set of experiments, that the best metric
should focus on the portion of the range where the highest accuracy is desired. For example, if
the ultimate aim is to generate alerts whenever a patient is at risk of hypoglycemia (<70 mg/dl
blood glucose level), then the chosen metrics should focus on this range in addition to the
overall range. In contrast, recent works in the literature (e.g. [12] as well as those covered in
the survey articles [10, 11]) usually compute accuracy over the entire glycemic range, which
may lead to misleading conclusions. A solution to this problem is to break the glycemic range
into meaningful parts and then analyse each subrange separately.
Secondly, once the importance of this approach is established, further analysis in this paper
then shows that the naive application of machine learning models to the data does indeed lead
to bias. This is because most T1D patients spend most of the time in the normal range. Since
there is very little work in the literature on the problem of imbalanced regression [13], an
adaptation of standard preprocessing techniques for imbalanced labelled data, applied to
blood glucose level regression, is proposed here. This in turn leads to demonstrated increases
in accuracy on particular subranges of the glycemic range.
Materials
The data analysed is reviewed in this section and then the machine learning and preprocessing
methods used are summarised. Finally, typical metrics for assessing blood glucose level predic-
tors from the literature are described.
Ohio T1D dataset and prediction task
The University of Ohio T1D Dataset [14] is a publicly available benchmark dataset comprising
data from six T1D AP users taken over a period of approximately eight weeks. The dataset is
nontrivial in size and consists of detailed information from the patients including interstitial
glucose levels recorded by a Medtronic Enlite CGM, records of doses of basal and prandial
insulin administered by a Medtronic 530G insulin pump (including temporary basal rate
changes and corrective boluses), physiological data recorded by a Basis Peak fitness band (e.g.
heart rate) and a variety of self-reported data (such as self-reported sleeping times and food
intake estimates). A period of approximately eight weeks is covered for each patient which in
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turn is split chronologically into two parts: approximately the first six weeks of data are
reserved for training, and approximately the last two weeks are reserved for testing.
In this paper, the focus of analysis is on the timestamped CGM portion of the data. An
example of this type of data is given in Fig 1 which shows a fragment of CGM trace for one
patient over a period of approximately twenty hours. The horizontal lines on the graph are at
70 mg/dl and 180 mg/dl respectively which are are the thresholds for level 1 hypoglycemia and
level 1 hyperglycemia [15]. The normoglycemic range lies between these ranges.
A typical issue when dealing with this type of CGM data is gaps in the CGM trace which
may occur frequently and for multiple reasons. For example, sensor replacement necessarily
leads to a gap in the data of a varying amount of time; likewise forgetting to swipe a flash-type
sensor within eight hours may also lead to a gap. Both types of data gap are understandable
and expected.
However, dealing with these gaps can be problematic from a machine learning point of
view. Currently, it is not clear how to impute missing CGM trace data. Previous works have
addressed the problem of gaps by applying time series imputation methods, e.g. Kalman
Smoothing [12], but such methods may lead to bias since they require information from the
future before the imputation can be performed. Similarly, simple methods such as “last value
carried forward” may also induce bias.
In this work, the missing value problem is circumvented by considering only complete
trace fragments. To construct examples for the training and testing data, a sliding prediction
window technique is used. The prediction window length is 120 minutes (equivalent to 24 con-
secutive CGM readings at an interval of five minutes between readings) with the target value
for each prediction window being CGM reading 30 minutes after the end of the prediction
window. If a sliding prediction window has less than 24 readings, it must contain a gap and
therefore it is discarded. Table 1 gives the number of examples in the training and testing data-
sets for each patient after this process. The table also shows the patient identifiers from the
Fig 1. A sample of a few hours of CGM data from one patient. The horizontal red line indicates the boundry
between normoglycemia and hyperglycemia according to [15]. Note (i) the two gaps in the trace, one shorter and one
longer; and (ii) maximum possible sensor reading of 400 mg/dl, even though glucose levels can exceed this amount.
This patient experienced hypoglycemia just after 1am followed by severe hyperglycemia later in the morning.
https://doi.org/10.1371/journal.pone.0225613.g001
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Ohio T1D dataset as well as the randomly-shifted date ranges that each dataset covers to
emphasise that the test data occurs after the training data.
In the Introduction, it was mentioned that the CGM data is imbalanced across the different
glycemic ranges because T1D patients spend most of their time in normoglycemia. This is
illustrated in Fig 2, which depicts a frequency histogram over CGM sensor readings across the
entire Ohio dataset. The figure clearly shows that the bulk of the sensor readings are normogly-
cemic with only 2,141/63,622 (3.4%) being hypoglycemic and 21,707/63,622 (34.1%) being
hyperglycemic. Therefore imbalance is a serious issue in this data, and consequently it can be
expected that most models learned using machine learning algorithms will be biased towards
predicting values in the normoglycemic range.
Machine learning regression models
In this section, ten different machine learning algorithms used for training regression models
are outlined. These models are well known in the literature, and where appropriate citations
are provided. The models are described in approximate order from the most interpretable (i.e.
Table 1. Number of examples in each training set after processing the CGM traces with the sliding window technique, along with the start and end dates (randomly
shifted) for each dataset.
Patient Training Size Train Dates Testing Size Testing Dates
559 9,517 7/12/21–17/1/22 2,163 18/1/22–27/1/22
563 11,500 13/09/21–28/10/21 2,460 29/10/21–7/11/21
570 10,364 7/12/21–16/1/22 2,453 17/1/22–26/1/21
575 9,821 17/11/21–1/1/22 2,289 2/1/22–11/1/21
588 12,332 30/8/21–14/10/21 2,701 15/10/21–24/10/21
591 10,088 30/11/21–13/1/22 2,621 14/1/22–23/1/22
https://doi.org/10.1371/journal.pone.0225613.t001
Fig 2. Frequency histogram showing counts of CGM sensor readings for all patients in the training data. Different
colours indicate whether or not the sensor reading is normoglycemic or not.
https://doi.org/10.1371/journal.pone.0225613.g002
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so-called “transparent” or “white box” models) to the least interpretable (so-called “black box”
models).
Dummy. The dummy model constantly predicts the mean blood glucose level of the
patient, computed from that patient’s training data. As such, it is not a “true” model and poor
predictive performance is expected, but it is included as a baseline method for comparison
with the other approaches.
Lasso. The Lasso algorithm constructs a sparse linear predictive model [16, 17]. The
model is sparse in that it uses L1 regularisation to set as many model coefficients to zero as pos-
sible. It is well known that blood glucose dynamics are distinctly non-linear and therefore
Lasso in its naive direct application would not be suitable for this problem. The Lasso algo-
rithm is therefore modified to enable it to capture non-linear dynamics by creating additional
“polynomial” features from the original features, and training the model on this expanded set
of features. Eq 1 illustrates this, with b^g tþ30 being the model’s thirty minutes ahead prediction,
xi being the ith CGM sensor reading in the sliding prediction window, and βi being the ith
coefficient of the model.
b^g tþ30 ¼ b0 þ b1x1 þ b2x2 þ � � � þ b24x24
þb25x21 þ b26x1x2 þ � � � þ b48x1x25
þb49x22 þ b50x2x3 þ � � �
� � �
ð1Þ
Eq 1 shows that the first twenty five terms correspond to a linear model consisting of an
intercept and one coefficient per input variable. However, subsequent terms correspond to
non-linear inputs which are either squares of each individual input or interactions calculated
by taking feature products. While a Lasso model trained on normal and polynomial features
has a significantly higher dimensionality than a model trained using normal features only, the
tendency towards sparsity induced by L1 regularisation should produce a model that is both
accurate and concise.
Support vector regression (linear kernel). An alternative method for training an additive
linear model on a set of features and their polynomial combinations is to use the support vec-
tor regression (SVR) [18] instead. Support vector machines were originally formulated for
binary class (i.e. positive vs. negative) classification. The basic idea is to find via an optimisa-
tion process the so-called “maximum margin hyperplane” that separates examples from the
two classes with the widest possible margin. This idea can also be applied to regression, but
instead of maximally separating examples, the hyperplane that best fits the target values of the
examples is found instead. Predictions are made by evaluating this hyperplane at new points.
In this approach, L1 regularisation is still utilised so that as many polynomial features are elim-
inated as possible. SVR-based linear models often produce significantly more accurate models
than other linear regression approaches such as Lasso.
Decision tree. A decision tree is a non-parametric approach to learning a regression
model [19]. The basic idea is to repeatedly learn simple decision rules, each rule focusing on a
single basic feature in the data. For example, if x3 represents the CGM reading twenty minutes
ago in a prediction window, then a simple decision rule involving this feature is “if x3 > 140
mg/dl then predict 160 mg/dl else predict 150 mg/dl”. Multiple decision rules can be stacked
on each other, producing a decision tree. Fig 3 illustrates a very simple decision tree. Advan-
tages of decision trees include simplicity, ease of understanding, and the relative straightfor-
wardness of algorithms for learning such a tree from data. On the other hand, decision tree
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learning algorithms may produce models that are overly complex and/or biased if the data is
imbalanced.
K-Nearest Neighbour. Like decision tree learning algorithms, the K-Nearest Neighbour
algorithm is relatively simple. The idea is that instead of building a model explicitly, the entire
training dataset is simply memorised. When a prediction for a new example is required, the K
closest examples to the new example are determined using a particular distance function.
Since these examples are labelled with their own b^g tþ30 values, then a new prediction is formed
by averaging (either simply or in a weighted fashion) over the K closest predictions.
Support vector regression (radial basis function kernel). An alternative formulation of
SVR is to replace the simple linear kernel with a more complex non-linear kernel. A frequently
used choice for this is a radial basis function (RBF) kernel. Since the model itself is non-linear,
SVR with an RBF kernel can be surmised to more naturally model the blood glucose dynamics
in the data. Consequently, polynomial feature construction is not performed for this approach.
The model is also trained differently using the nuSVR algorithm proposed by [20]. It is not
expected that models produced via this approach will be interpretable compared to those pro-
duced by the linear kernel approach.
Multilayer Perceptron (single hidden layer). Multilayer Perceptions (MLPs) are another
common method for learning complex non-linear models from data. An MLP for glucose
Fig 3. Illustration of a decision tree used for regression. Intermediate nodes represent tests of the features and leaf
nodes are predictions for b^g tþ30.
https://doi.org/10.1371/journal.pone.0225613.g003
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level prediction is depicted by Fig 4. The inputs (CGM sensor readings x0, x1, . . .) are aggre-
gated and non-linearly transformed at intermediate points known as hidden nodes (the hi
nodes in the figure) before being aggregated and transformed again to produce the final pre-
diction b^g tþ30. In contrast to sparse linear models, MLPs are typically not interpretable due to
the complexity of the model.
In an MLP, each edge in the graph represents a distinct numeric parameter that must be
optimised by the training process. Note also that some of the edges from the diagram: further
edges connecting a constant input to each non-input node are also usually present. The
ADAM algorithm [21] is used to train the MLPs.
Multilayer Perceptron (two hidden layers). An MLP capable of learning more complex
patterns in the data is one that comprises two hidden layers. A two hidden layer variant is
therefore also included in the experiments that follow.
Random forest. In contrast to a single decision tree, a random forest [22] is an ensemble
of decision trees. In the ensemble, each individual tree makes its own predictions, which are
averaged or otherwise aggregated across the entire ensemble to produce a final overall predic-
tion. A key point about the random forest ensemble is that each decision tree is trained on a
different randomly selected subset of the input features. This produces a diverse set of individ-
ual decision trees. When the predictions of an ensemble are aggregated, the aggregated predic-
tion is generally more accurate than any single decision tree. A distinct drawback is that like
MLPs, random forest models are often complex and difficult to interpret due to the number of
Fig 4. Illustration of a MLP with a single hidden layer of size five.
https://doi.org/10.1371/journal.pone.0225613.g004
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decision trees and their size. In contrast, a single decision tree such as that shown in Fig 3 is
often relatively straightforward to understand provided it is not too large.
Gradient boosting. Gradient boosting approaches [23] offer an alternative means of con-
structing a decision tree ensemble in which each decision tree is trained in sequence instead of
independently. The idea is for each consecutive decision tree to learn from the prediction
errors of the earlier decisions trees. Predictions from each individual decision tree are then
aggregated via weighted summation with appropriately selected weights. Because gradient
boosting learns individual decision trees in sequence rather than independently, it can be
slower than random forests (in which decision trees can be learned in parallel), but it is often
more accurate in practice.
Oversampling techniques
Oversampling techniques are one method of addressing the data imbalance problem in
machine learning. The data imbalance problem occurs because machine learning algorithms
make the implicit assumption that the data used for training is balanced across all likely cases.
If the data is not balanced, then some algorithms will produce models with significant bias.
To illustrate, suppose there are examples belonging to three sets: hypoglycemic, normogly-
cemic, and hyperglycemic. An ideal dataset would have a ratio of 33.3% from each range.
However, as Fig 2 shows, a more realistic situation is that the groups are imbalanced to a
significant degree. For example, 20%:40%:20% is a minor degree of imbalance that most
algorithms should cope with. However in the case of Fig 2 the ratio is more extreme at
3.4%:62.5%:34.1%. In this case, the data should be artificially balanced to prevent bias in the
model. Two such general approaches are possible: data can be either discarded (which would
mean removing the majority of data from the normoglycemia subset and most of the data
from the hyperglycemia subset), or synthetic data can be added to the smaller subsets to
increase their size. In this paper, this latter group of techniques known collectively as oversam-
pling algorithms is the focus, since initial experiments with discarded data yielded very poor
results.
These techniques all apply to labelled data and are usually used for approaching imbalanced
classification problems as opposed to regression problems. Therefore additional steps are
required to prepare the data before they can be applied in the context of blood glucose level
prediction. These steps are discussed in the next section. Note also that in all experimental situ-
ations the oversampling is applied only to the training data.
Random oversampling. The first technique, random oversampling, creates random
duplicates of examples in the dataset. This is performed for the non-majority subsets, which in
the case of T1D blood glucose level data is the hypoglycemic and hyperglycemic data. In both
cases, examples from these sets are randomly duplicated until the size of both subsets is equal
to the size of the normoglycemia subset.
Synthetic minority oversampling technique. The second approach, Synthetic Minority
Oversampling Technique (SMOTE) [24] is based on the assumption that the minority class
examples occur relatively close together in the space of examples. This is usually true when the
data contains clusters. Rather than randomly duplicating examples, SMOTE instead creates
entirely new “artificial” examples based on this assumption of clustered data. The process
involves taking an initial randomly selected minority class example (e.g. an example from the
hypoglycemia subset) and then locating nearby similar examples from the same subset. The
artificial example is then created by interpolating randomly between the initial example and
one of the nearby similar examples, with the amount of interpolation again selected randomly.
Fig 5 illustrates this graphically.
Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning
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In the figure, the nodes represent a group of neighbouring minority class examples in the
space of examples that are similar to xi, and xj is randomly selected from amongst them. The
procedure for creating xnew is basic linear interpolation between xi and xj as shown by Eq 2,
with a randomly selected parameter λ used to control the degree of contribution that each of
the examples makes to the new example. In this way new synthetic minority classes can be gen-
erated until the classes are more balanced.
xnew ¼ xi þ lðxj   xiÞ; l 2 ½0; 1� ð2Þ
Adaptive synthetic oversampling technique. The third and final approach, Adaptive
Synthetic (ADASYN) [25], takes a similar approach as SMOTE. However, ADASYN addition-
ally distinguishes between examples that are “easy” to learn vs. those that are “hard” to learn in
the choice of which real examples to use for generating the synthetic examples. The “difficulty”
of a real example is determined by comparing the example with its K nearest neighbours (in a
fashion similar to the K Nearest Neighbours algorithm described previously), the intuition
being that if most of the neighbours are the same, then the example is easy, whereas if most of
the neighbours are different, the example if difficult. The fraction of the K nearest neighbours
Fig 5. Illustration of SMOTE’s artificial example generation technique.
https://doi.org/10.1371/journal.pone.0225613.g005
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that are from the same minority subset or class are therefore calculated and becomes a proxy
for the difficulty of the example.
Next, the synthetic examples are generated from real examples. Whereas SMOTE treats all
examples as equal, in ADASYN the number of synthetic instances that a particular minority
class example is used to generate is proportional to that example’s difficulty. Therefore, in Fig
5, it can be assumed that the real examples xi is most likely to be a difficult example.
Metrics for assessing predictive performance
Two different but complementary metrics are often used in literature relating to CGM data.
The first, Mean Absolute Relative Difference (MARD), is a measure of predictive error and is
defined by Eq 3.
MARD ¼
100
N
XN
t¼1
jb^g tþ30   bgtþ30j
bgtþ30
ð3Þ
In the equation, N is the number of predictions made, b^g tþ30 is the predicted blood glucose
level thirty minutes in advance at time t, and bgt+30 is the actual blood glucose level that
occurred. The errors are converted to a percentage and averaged to give an overall measure of
predictive performance. This approach is especially useful for the analysis of blood glucose
level predictions because the significance of different absolute prediction errors varies depend-
ing on where in the glycemic range the prediction is made. For example, in the hypoglycemic
range an error of 10% is much smaller (in absolute mg/dl units) than the same percentage
error in the hyperglycemic range. In contrast a significant number of papers in this area use
alternative metrics such as root mean squared error (e.g. see the survey paper [11] and recent
papers on the blood glucose prediction competition [26]) which are based on absolute units of
mg/dl and may result in biased performance estimates.
The second means of assessing predictive performance is the Clarke Error Grid Analysis
(EGA) [27], a more clinically oriented approach. Although EGA was originally devised for
assessing the accuracy of CGMs themselves by comparing such devices to different reference
devices with known accuracy, they can also be used for assessing the predictions made by
regression models.
Fig 6 depicts the grid used for EGA. As the figure shows, if the prediction/ground truth
pairs fall on a 45˚ line that passes through the origin, then the predictions are perfect. Since
most predictions are not perfect, however, the idea behind Clarke EGA is that different errors
will have different clinical consequences depending on where they fall in the range as well as
their magnitude. In contrast, MARD is only concerned with the size of the error regardless of
location.
In a Clarke grid, the most preferred errors lie in Zone A which, as Fig 6 shows, is either the
area where the patient will be hypoglycemic (<70 mg/dl blood glucose level) and the predic-
tion is hypoglycemic, or the prediction is within 20% error of the ground truth. Zone B is simi-
lar to Zone A, but excludes the hypoglycemic region and permits a larger percentage error.
The theory is that the patient would self-administer correct treatment if the error is in Zone A,
while the treatment would be “not inappropriate” in Zone B.
Conversely, Zones C, D and E represent prediction errors potentially leading to clinical
errors. Specifically, Zone C errors are likely to lead to unnecessary treatments (e.g. the patient
will be normoglycemic but predicted to be hyperglycemic) while Zone D and E represent
errors that could lead to potentially dangerous treatments (e.g. the patient will be hypoglyce-
mic but is predicted to be hyperglycemic). Therefore a good strategy for model selection
Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning
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involves maximising the number of prediction errors falling into Zone A while minimising the
number of errors in the other zones. A disadvantage of this approach is that involves analysing
five metrics (i.e. the percentage of errors in each zone) as opposed to one metric, but these
numbers provide additional insight.
Methods
In this section the methods and experimental setup used are described.
Glycemic-aware metrics and oversampling techniques
Based on the unique nature of the glycemic range and the fact that errors in different parts of
the range have considerably different impacts, variants of the standard MARD metric are pro-
posed in this section.
Errors in the hypo-/hyperglycemic ranges are much more significant than errors in the nor-
moglycemic range. The MARD formula from Eq 3 can therefore be generalised by selecting
only specific ground truth values bgt+30 and performing the MARD calculation on those. It is
assumed that there is some criteria C available such that C(bgt+30) is true for some ground
Fig 6. Clarke error grid analysis, reproduced from [28].
https://doi.org/10.1371/journal.pone.0225613.g006
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truth sensor values and false otherwise. A revised version of the MARD formula therefore is
given in Eq 4.
MARDC ¼
100
NC
XN
t¼1
jb^g tþ30  bgtþ30j
bgtþ30
if Cðbgtþ30Þ ¼ true
0 otherwise
8
<
:
ð4Þ
In Eq 4, C denotes a criteria while NC is the number of predictions for which the criteria is
true, and the rest of the symbols are defined as previously. The criteria is used to split the pre-
dictions into three specific subsets: predictions whose ground truth is in the hypoglycemic
range (MARD<70); predictions whose ground truth is normal (MARDnorm); and predictions
whose ground truth is in the hyperglycemic range (MARD>180). Overall MARD calculated
according to Eq 3 will now be referred to as MARDall.
Next, glycemic-friendly variants of the oversampling techniques are proposed. Since glu-
cose level prediction is a regression problem, there are no class labels as such. Instead, exam-
ples are labelled with a numeric target value bgt+30. Oversampling techniques such as those
described previously cannot therefore be applied directly to the data.
To solve this problem, fake or “pseudolabels” for the examples are generated and used. The
pseudolabels, like the MARD variants above, can be specifically designed for the glycemic
range by discretising the target value into three parts (i.e. hypo-, normo- and hyperglycemic).
The range then determines the pseudolabel. Table 2 illustrates the process for six examples
from the dataset. The pseudolabels can be discarded after the oversampling procedure is
complete.
Note that a key novel difference between the oversampling proposed here and standard
oversampling techniques is that the numeric targets (i.e. the bgt+30 values) are also synthetically
generated with the features. In contrast, standard approaches usually only synthetically gener-
ate the features of each example while keeping the labels fixed.
Experimental setup
To evaluate the range of machine learning algorithms described in the previous section against
the Ohio T1DM dataset, the following experiment was devised. Firstly the ten machine learn-
ing algorithms (dummy, Lasso, decision tree, etc) were combined with four oversampling
options. The four oversampling options were no oversampling (as a baseline), random over-
sampling, SMOTE, and ADASYN. This yielded a total of forty different combinations.
Next, each of the forty combinations was trained six times, against each individual patient’s
training data. The resulting models were then tested against each patient’s corresponding test
dataset (see Table 1 as a reminder of the size of each dataset). Thus, a total of 240 train/test
experiments were performed.
Table 2. Examples of feature vectors constructed from the CGM traces. Features x1 to x24 are consecutive CGM sen-
sor readings occurring over a period of 120 minutes; bgt+30 is the glucose value observed 30 minutes after x24. The pseu-
dolabel for each example, which is only used if an oversampling method is employed, is also shown.
x1 x2 . . . x23 x24 bgt+30 Pseudolabel
215 209 . . . 158 151 125 Lnormal
149 137 . . . 109 113 133 Lnormal
165 163 . . . 171 174 187 L>180
154 158 . . . 217 217 234 L>180
65 70 . . . 71 70 60 L<70
105 109 . . . 64 64 65 L<70
https://doi.org/10.1371/journal.pone.0225613.t002
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Once test data predictions were recorded, performance metrics were calculated. The met-
rics were MARDall, MARD<70,MARD>180 and MARDnorm, along with the percentage fre-
quencies of prediction errors falling into all five zones of the Clarke error grid.
In terms of preprocessing and hyperparameters used, feature-wise standardisation (with
the mean and standard deviation calculated based on the training data) was used to scale the
data before any of the machine learning algorithms were applied. For the Lasso model, five-
fold cross validation on the training data was used to select the optimal alpha parameter; for
the Lasso, SVR, and MLP models, the number of iterations was set at 100,000; and for the deci-
sion tree ensembles, the number of trees was set at 500. The MLP models additionally had the
size of each hidden layer fixed at five units, and the activation function for each hidden node
was tanh. All other parameters and settings were defaults as set in the sci-kit learn [29] v 0.20.3
and imbalanced learn [30] v 0.4.3 APIs.
Results
Complete and detailed tables of results with mean and standard deviation performances by
algorithm, oversampler and metric are given in S1 Appendix. In this section, summarised
results are primarily presented along with the results of various statistical tests.
However, it is prudent to note that an examination of the raw result tables shows that some
zones of the Clarke error grid are not useful for the purposes of selecting the best model. To
illustrate, consider Table D in S1 Appendix. In this table, the dummy method records 0% fre-
quency of prediction errors in EGA Zones C and E, which is the lower than all of the nine
other options in the table. Under the assumption that a lower error rate in these zones is
“safer”, this would imply that the dummy classifier has reasonably good predictive perfor-
mance. However, the error rates in Zone A show that the dummy classifier achieves only 33%
compared to 74% for the next best method. In other words, selecting a model based on the fre-
quencies of errors in Zones C and E is unreliable and these metrics should be given less weight
than the other metrics.
Table 3 gives the first summary of the results. In this table, all of the predictive model/over-
sampling combinations are ranked by overall MARDall and averaged across patient. The table
shows the top five algorithms in the ranking. Surprisingly, all of the best models are linear
models, but trained using the additional polynomial features. Linear SVR and no oversampling
achieves the best overall average value for MARDall.
The story is different when considering the proposed alternative range-specific MARD met-
rics, however. Table 4 presents the same ranking, but this time for the MARD<70, MARD>180
and MARDnorm metrics. The table shows that linear SVR’s excellent overall performance is pri-
marily due to accurate predictions being made in the normal range. In contrast, outside the
normal range (in both the hypo- and hyperglycemic subranges) an MLP with two hidden lay-
ers combined with some form of oversampling records the best prediction accuracy.
Table 3. Top five model and resampler combinations based on overall MARD.
Combination MARDall
Lin. SVR 10.19
Lasso + SMOTE 10.29
Lasso + Random 10.31
Lin. SVR + SMOTE 10.37
Lin. SVR + Random 10.39
https://doi.org/10.1371/journal.pone.0225613.t003
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To further investigate this, a standard paired t-test comparing the six MARD<70 values of
the best MLP classifier (MLP(5,5)+ADASYN) against the linear SVR approach was performed.
The linear SVR approach performed well overall (see Table 3), but poorly according the
MARD<70 metric, having an average error of 26.01 while the table shows that the best MLP
approach scored 12.46. This difference in mean performance was found significant at 95%
confidence with p = 0.025.
A similar comparison using the MARD>180 metric was also performed. Again, linear SVR
was compared to the best MLP classifier (MLP(5,5)+ADASYN this time) where the mean
errors were 8.74 and 8.19 respectively (see S1 Appendix for linear SVR’s MARD>180 result).
This time no significant difference at 95% confidence was found between the means with
p = 0.1795. The difference is significant at an 80% level of confidence, however.
Next, results from the Clarke EGA were examined. The top ranked algorithms as deter-
mined by percentage frequencies are given by Table 5. For Zone A, a higher percentage is
Table 4. Top five model and resampler combinations based on alternative MARD metrics.
Combination MARD>180 Combination MARDnorm
MLP(5,5) + Random 8.19 Lin. SVR 10.88
MLP(5,5) + SMOTE 8.23 MLP(5,5) 10.94
MLP(5) + SMOTE 8.27 GB 11.12
MLP(5) + Random 8.31 MLP(5) 11.17
MLP(5,5) 8.45 Lasso + Random 11.26
Combination MARD<70
MLP(5,5) + ADASYN 12.46
MLP(5,5) + SMOTE 13.20
MLP(5) + ADASYN 14.02
MLP(5,5) + Random 14.18
MLP(5) + SMOTE 14.85
https://doi.org/10.1371/journal.pone.0225613.t004
Table 5. Top five model and resampler combinations based on EGA metrics (excludes the dummy predictor).
Combination EGAA Combination EGAB
Lin. SVR 87.17 Lin. SVR 11.59
Lasso + Random 86.97 MLP(5,5) 11.76
Lasso + SMOTE 86.94 Lasso 11.86
Lasso + ADASYN 86.89 MLP(5) 12.01
Lin. SVR + SMOTE 86.73 GB 12.15
Combination EGAC Combination EGAD
KNN + Random 0.00 MLP(5) + Random 0.51
KNN + ADASYN 0.00 MLP(5) + ADASYN 0.52
KNN 0.01 MLP(5) + SMOTE 0.55
KNN + SMOTE 0.01 NuSVR + Random 0.57
NuSVR + ADASYN 0.02 NuSVR + SMOTE 0.57
Combination EGAE
DT 0.00
KNN 0.00
KNN + Random 0.00
KNN + SMOTE 0.00
KNN + ADASYN 0.00
https://doi.org/10.1371/journal.pone.0225613.t005
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better since this represents the most benign class of error; for other zones, a lower rate is better.
This table tells a similar story to that of the MARD-based analysis: linear SVR achieves the best
results in terms of Zone A and B errors, while the MLP approach with oversampling is most
effective at minimising the more dangerous Zone D errors. For the Zone C and E errors,
results from the dummy method were excluded and consequently decision trees and KNN
achieve the best performance in these zones. However, like the dummy method, decision trees
and KNN perform poorly according to the other metrics, and therefore the Zone C/E frequen-
cies are excluded from further analysis.
Table 6. Friedman test p-values after testing for the null hypothesis that all classifiers perform equally well.
Metric p value
MARDall 1.573e-05
MARD<70 0.1309
MARDnorm 0.0001133
MARD>180 0.001298
EGAA 0.004514
EGAB 0.0004646
EGAD 0.007071
https://doi.org/10.1371/journal.pone.0225613.t006
Fig 7. Examples of a prediction made by linear SVR for one patient. The first 120 minutes of the plot (unfilled
circles) are the inputs to the model; the last reading at 150 minutes is the prediction (unfilled) and what actually
happened (filled). This figure depicts a Type A error.
https://doi.org/10.1371/journal.pone.0225613.g007
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A Friedman test [31] comparing all forty machine learning/oversampler combinations
across all six patients was also performed. The Friedman test is a statistical test for determining
if all the prediction methods perform the same or differently. The test was performed once for
each metric, and the p-values are given in Table 6. These values indicate that in all cases except
MARD<70, there is a strongly significant difference (more than 99% confidence) between the
predictive accuracies. For the MARD<70 case, confidence is more than 80% but less than 95%.
A further posthoc Nemenyi test [32] was also performed in order to isolate the best subset of
equivalent methods, but this test failed to produce significant results. This is most likely due to
the small number of patients in the dataset.
Finally, some examples of predictions made by the linear SVR method are shown in Figs 7
and 8. In both situations, the prediction is that the patient will be hypoglycemic in the next
thirty minutes; in one case the prediction is correct (a Type A error) and in the second case it
is seriously wrong (a Type E error). One possible explanation for the Type E error is that the
patient ate something in the interval between the end of the prediction window and the predic-
tion point thirty minutes later.
Discussion
There are two main takeaways from the results presented here. Firstly, relying on a single over-
all metric for model selection (often a standard approach in machine learning) is unlikely to be
sufficient since it will not reveal information on the predictive accuracy of a method in sub-
ranges that are rarely visited. The main illustration here is the<70 mg/dl range where
Fig 8. Similar example to that depicted in Fig 7, but depicting a Type E error.
https://doi.org/10.1371/journal.pone.0225613.g008
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performance of the best overall method was significantly poorer than another method. Analy-
sis should instead follow an approach similar to that performed here: break the overall error
metric down into its constituent parts and analyse each constituent part separately. Alternative
clinical metrics such as those derived from Clarke EGA are also extremely useful and could
even be the primary method of evaluation.
The second important takeaway is that the datasets used for training the model will be
imbalanced, and it is shown here that techniques addressing imbalance improve accuracy.
Again, prior works will often ignore this issue and therefore the results they present are most
likely biased.
To conclude, some recommendations for the most appropriate approaches for predicting
blood glucose levels can be made. The results show that if the application is hypoglycemia
alerting, an MLP trained in conjunction with an oversampling method produces the best accu-
racy. On the other hand, for general forecasting of blood glucose levels over the� 70 mg/dl
range, a linear SVR trained on prediction window sensor readings plus polynomial features
calculated from the original readings is the closest approach to optimal. Thus, the choice of
best algorithm to use depends on where in the glycemic range it will be applied. In contrast,
most other works in the literature do not perform this kind of breakdown analysis of predic-
tions across different regions of the glycemic range. A strong recommendation therefore for
future work is to analyse model errors by subrange, using both numeric metrics such as
MARD and clinical metrics such as EGA. Additionally, if general purpose prediction across
the entire range is required, researchers could consider the use of multiple models, each model
optimised for its own particular glycemic subrange.
Supporting information
S1 Appendix. Complete and detailed tables of results with mean and standard deviation
performances by algorithm, oversampler and metric.
(PDF)
Author Contributions
Conceptualization: Michael Mayo, Lynne Chepulis, Ryan G. Paul.
Investigation: Michael Mayo.
Methodology: Michael Mayo.
Software: Michael Mayo.
Validation: Michael Mayo.
Writing – original draft: Michael Mayo.
Writing – review & editing: Michael Mayo, Lynne Chepulis, Ryan G. Paul.
References
1. DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. The Lancet. 2018; 391(10138):2449–2462.
https://doi.org/10.1016/S0140-6736(18)31320-5
2. Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, et al. Continuous Glucose Monitoring
vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple
Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA. 2017; 317(4):379–387. https://
doi.org/10.1001/jama.2016.19976 PMID: 28118454
3. Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, et al. Glucose Out-
comes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and
Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning
PLOS ONE | https://doi.org/10.1371/journal.pone.0225613 December 2, 2019 17 / 19
Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 2017; 19(3):155–163. https://doi.
org/10.1089/dia.2016.0421
4. Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, et al. Current State of Type
1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry. Diabetes
Care. 2015; 38(6):971–978. https://doi.org/10.2337/dc15-0078 PMID: 25998289
5. Rama Chandran S, Tay WL, Lye WK, Lim LL, Ratnasingam J, Tan ATB, et al. Beyond HbA1c: Com-
paring Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2
Diabetes. Diabetes Technology & Therapeutics. 2018; 20(5):353–362. https://doi.org/10.1089/dia.
2017.0388
6. Abraham MB, Nicholas JA, Smith GJ, Fairchild JM, King BR, Ambler GR, et al. Reduction in Hypoglyce-
mia With the Predictive Low-Glucose Management System: A Long-Term Randomized Controlled Trial
in Adolescents With Type 1 Diabetes. Diabetes Care. 2017. https://doi.org/10.2337/dc17-1604 PMID:
29191844
7. Del Favero S, Place J, Kropff J, Messori M, Keith-Hynes P, Visentin R, et al. Multicenter outpatient din-
ner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artifi-
cial pancreas using modular model predictive control in adults with type 1 diabetes. Diabetes, Obesity
and Metabolism. 2015; 17(5):468–476. https://doi.org/10.1111/dom.12440 PMID: 25600304
8. Bruen D, Delaney C, Florea L, Diamond D. Glucose sensing for diabetes monitoring: recent develop-
ments. Sensors. 2017; 17(8):1866. https://doi.org/10.3390/s17081866
9. Kovatchev B. Automated closed-loop control of diabetes: the artificial pancreas. Bioelectronic Medicine.
2018; 4(1):14. https://doi.org/10.1186/s42234-018-0015-6
10. Oviedo S, Vehı´ J, Calm R, Armengol J. A review of personalized blood glucose prediction strategies for
T1DM patients. International Journal for Numerical Methods in Biomedical Engineering. 2017; 33(6):
e2833. https://doi.org/10.1002/cnm.2833
11. Woldaregay AZ, Årsand E, Walderhaug S, Albers D, Mamykina L, Botsis T, et al. Data-driven modeling
and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes. Artificial
Intelligence in Medicine. 2019; 98:109–134. https://doi.org/10.1016/j.artmed.2019.07.007. PMID:
31383477
12. Marling C, Bunescu R. Benchmark Machine Learning Approaches with Classical Time Series
Approaches on the Blood Glucose Level Prediction Challenge. In: Proc. of the 3rd International Work-
shop on Knowledge Discovery in Healthcare Data; 2018. p. 97–102.
13. Branco P, Torgo L, Ribeiro RP. A Survey of Predictive Modeling on Imbalanced Domains. ACM Comput
Surv. 2016; 49(2):31:1–31:50. https://doi.org/10.1145/2907070
14. Marling C, Bunescu R. The OhioT1DM Dataset For Blood Glucose Level Prediction. In: Proc. of the 3rd
International Workshop on Knowledge Discovery in Healthcare Data; 2018. p. 60–63.
15. Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International Consensus on
Use of Continuous Glucose Monitoring. Diabetes Care. 2017; 40(12):1631–1640. https://doi.org/10.
2337/dc17-1600 PMID: 29162583
16. Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate
Descent. Journal of Statistical Software, Articles. 2010; 33(1):1–22.
17. Kim SJ, Koh K, Lustig M, Boyd S, Gorinevsky D. An Interior-Point Method for Large-Scale L1-Regular-
ized Least Squares. IEEE Journal of Selected Topics in Signal Processing. 2007; 1(4):606–617. https://
doi.org/10.1109/JSTSP.2007.910971
18. Smola AJ, Scho¨lkopf B. A tutorial on support vector regression; 2004.
19. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Monterey, CA:
Wadsworth and Brooks; 1984.
20. Scho¨lkopf B, Smola AJ, Williamson RC, Bartlett PL. New Support Vector Algorithms. Neural Comput.
2000; 12(5):1207–1245. https://doi.org/10.1162/089976600300015565 PMID: 10905814
21. Kingma DP, Ba J. ADAM: A method for stochastic optimization. arXiv preprint arXiv:14126980. 2014.
22. Breiman L. Random forests. Machine Learning. 2001; 45(1):5–32. https://doi.org/10.1023/
A:1010933404324
23. Friedman JH. Stochastic Gradient Boosting. Comput Stat Data Anal. 2002; 38(4):367–378. https://doi.
org/10.1016/S0167-9473(01)00065-2
24. Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: Synthetic Minority Over-sampling Tech-
nique. J Artif Int Res. 2002; 16(1):321–357.
25. He H, Bai Y, Garcia EA, Li S. ADASYN: Adaptive synthetic sampling approach for imbalanced learning.
In: 2008 IEEE International Joint Conference on Neural Networks (IEEE World Congress on Computa-
tional Intelligence); 2008. p. 1322–1328.
Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning
PLOS ONE | https://doi.org/10.1371/journal.pone.0225613 December 2, 2019 18 / 19
26. Zhu T, Li K, Herrero P, Chen J, Georgiou P. A Deep Learning Algorithm for Personalized Blood Glucose
Prediction. In: Proc. of the 3rd International Workshop on Knowledge Discovery in Healthcare Data;
2018. p. 64–78.
27. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for
self-monitoring of blood glucose. Diabetes care. 1987; 10(5):622–628. https://doi.org/10.2337/diacare.
10.5.622 PMID: 3677983
28. Clarke error grid analysis https://commons.wikimedia.org/wiki/File:Clarkeerrorgrid.gif.
29. Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: Machine
Learning in Python. Journal of Machine Learning Research. 2011; 12:2825–2830.
30. Lemaıˆtre G, Nogueira F, Aridas CK. Imbalanced-learn: A Python Toolbox to Tackle the Curse of Imbal-
anced Datasets in Machine Learning. Journal of Machine Learning Research. 2017; 18(17):1–5.
31. Hollander M, Wolfe D, Chicken E. Nonparametric Statistical Methods, 3rd Edition; 2015.
32. Sachs L. Angewandte Statistik, 8th Ed.; 1997.
Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning
PLOS ONE | https://doi.org/10.1371/journal.pone.0225613 December 2, 2019 19 / 19
